Baxter International has received 510(k) clearance from the US Food and Drug Administration (FDA) for its next-generation Sigma spectrum infusion pump with Master Drug Library.


The new additions to the infusion pump include increased capacity of the master drug library, new asset-tracking capabilities.

The master drug library is safety software that enables a hospital to maintain a customized in-house library of facility-defined dosing parameters for infusions to minimize the likelihood of drug errors during care.

With Master Drug Library, the infusion pump provides multiple safety features, including dose error reduction software (DERS) and an automatic default to use of the drug safety library at the initial start of dose programming.

It also provides an option for wireless connectivity to integrate data into a hospital’s electronic medical record (EMR) system, to facilitate the transfer of data to and from the system for updating drug libraries, and to create continuous quality improvement reports.

According to the company, the new asset-tracking capabilities will allow hospitals to effectively locate, manage and deploy SIGMA Spectrum inventory, helping to ensure efficient allocation of hospital assets.

Baxter’s Hospital Products business president Brik Eyre said clinicians are looking for integrated systems that are efficient and cost effective, and allow hospital staff to focus on providing quality care for patients.

”We are excited to bring the next generation of Baxter’s SIGMA Spectrum Infusion Pump with Master Drug Library and its advanced, patient-centered safety technology to the U.S. marketplace,” Eyre added.

The company anticipates launching the next-generation SIGMA Spectrum with select healthcare facilities beginning in the summer of 2014.

Image: Baxter’s next-generation Sigma spectrum infusion pump with master drug library improvements include increased drug library capacity and device tracking services. Photo: courtesy of